• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    日

    日本中央競馬會

    japanese racing association
    234论文总数
    2,333引用总数

    论文量&引用量时间轴

    机构学者

    论文(234)

    年份
    起
    –
    止
    排序
    1Pharmacokinetic/Pharmacodynamic Analysis of Quinidine-Induced Dominant Frequency Reduction in Thoroughbred Horses with Atrial Fibrillation.
    Taisuke Kuroda,Yohei Minamijima,Yuji Takahashi, Yusaku Ebisuda, Kaori Yoshida, Hiroshi Ishikawa, Kei-Ichi Ishihara,Hiroshi Mita,Motoi Nomura,Toshio Nukada,Yuhiro Ishikawa

    Quinidine has long been used for the pharmacological treatment of atrial fibrillation (AF) in horses; however, the plasma concentration required for conversion to sinus rhythm remains unclear. Dominant frequency (DF), derived from surface electrocardiograms, reflects atrial activation rate during AF. This study aimed to quantify the relationship between plasma quinidine concentration and DF using a pharmacokinetic/pharmacodynamic (PK/PD) approach. Ten Thoroughbred horses with naturally occurring AF received quinidine sulfate via a nasogastric tube. Plasma quinidine concentrations and DF values, calculated from digitized atrial fibrillatory segments, were measured during treatment. PK/PD was analyzed using a sigmoid inhibitory Emax model, with typical parameters including a baseline DF of 6.27 Hz, a maximal DF reduction of 3.63 Hz, a theoretical minimum DF of 2.64 Hz, an EC50 of 0.78 μg/mL, and a Hill coefficient of 1.81. Nine horses converted to sinus rhythm, with median DF decreasing from 6.4 Hz to 3.0 Hz immediately before conversion. Model simulations indicated a pharmacodynamic plateau, with an increase in plasma quinidine concentration from 4 to 5 μg/mL resulting in only a 0.06-Hz reduction in DF. A model-predicted plasma quinidine concentration of 2.6 μg/mL achieved a DF of 3.0 Hz and may represent a target concentration for conversion.

    2026Journal of veterinary pharmacology and therapeutics(2026)
    引用
    AI阅读
    加入学术空间
    2Identification of a Novel Slow-Gray STX17 Lineage in Japanese Thoroughbreds Via a Multi-tiered Copy Number Analysis Workflow
    Koki Kawate,Risako Furukawa, Mio Kikuchi,Taichiro Ishige,Kazuhiro Seki,Teruaki Tozaki,Hironaga Kakoi

    Gray is a dominant coat color phenotype in horses caused by a 4.6 kb tandem triplication within intron 6 of syntaxin 17 (STX17). The copy number variation (CNV) of the duplicated segment influences the graying rate. The rare G2 allele (CNV = 2) is associated with a slower graying rate compared to the common G3 allele (CNV = 3) and is also relevant to melanoma risk. Current assays are limited because long and accurate PCR (LA-PCR) detects only the presence or absence of duplications, while droplet digital PCR (ddPCR) cannot reliably distinguish certain genotypes such as G3/g and G2/G2. We constructed a stepwise workflow combining (i) multiplex real-time PCR targeting the duplication junction for rapid gray/non-gray screening, (ii) ddPCR for copy number estimation, and (iii) LA-PCR for confirmatory genotyping of ambiguous copy-number classes. Using real-time PCR, we screened 4596 Japanese Thoroughbreds aged 2–7 years, of which 4374 were classified as non-gray and 222 as gray. Based on age and coat appearance, 23 Gy candidates were prioritized for slow-gray evaluation and analyzed by ddPCR; one was classified as G2/g, and 22 as G3/g or G2/G2. LA-PCR detected a g-derived band in all 22 cases, confirming that they were G3/g. Pedigree analysis suggested that the G2 allele was transmitted through the maternal line and that this lineage was distinct from the previously reported Japanese slow-gray family. This workflow enables practical molecular discrimination among non-gray, common gray, and slow-gray genotypes, supporting the surveillance of rare G2 alleles in the Japanese Thoroughbred population.

    2026Biochemical Genetics(2026)
    引用
    AI阅读
    加入学术空间
    3Equine Herpesvirus Myeloencephalopathy-Associated Mutations in Equine Herpesvirus 1 DNA Polymerase Confer the Ability to Replicate at Elevated Temperatures
    Noriko Fukushi,Rikio Kirisawa,Fuka Nishimura,Koji Tsujimura,Yuko Toishi,Hideto Fukushi

    Equine herpesvirus myeloencephalopathy (EHM), caused by equine herpesvirus type 1 (EHV-1), poses a major threat to the equine industry because of its devastating impact on animal welfare and athletic performance. A single-nucleotide polymorphism (SNP), G2254, in ORF30 (UL30), which encodes the viral DNA polymerase, has been used as a marker of neuropathogenic EHV-1 strains, although its contribution to EHM pathogenesis remains controversial. In addition, other ORF30 SNPs have been reported in association with EHM, but their functional significance is unclear. Clinical observations indicate that fever and high levels of viremia are closely associated with EHM onset. Here, we investigated EHV-1 replication under elevated-temperature conditions that mimic febrile states using a fetal horse kidney cell line, equine peripheral blood mononuclear cells (PBMCs), and equine vascular endothelial cells (EVECs). EHV-1 isolates derived from horses with EHM consistently retained the ability to replicate at elevated temperature in permissive cells and remained competent for infection despite restricted replication in PBMCs, whereas replication of many non-EHM-derived isolates was suppressed. Specific ORF30 SNPs were associated with replication at elevated temperatures, and a molecular epidemiological association analysis of these SNPs suggested an association with EHM. Together, these findings suggest that replication at febrile temperature is a viral property relevant to EHV-1 pathogenesis and EHM risk. IMPORTANCE:Equine herpesvirus myeloencephalopathy (EHM), caused by equine herpesvirus type 1 (EHV-1), represents a serious threat to the equine industry. Here, we show that EHV-1 field isolates and recombinant viruses harboring EHM-associated UL30 variants retain replication capacity at elevated temperatures in fetal horse kidney cells and equine vascular endothelial cells, and that peripheral blood mononuclear cells (PBMCs) infected with EHM-associated viruses can mediate cell-to-cell transfer under these conditions. In contrast, replication of many non-EHM-derived isolates and recombinant viruses in these cells, as well as PBMC-mediated cell-to-cell transfer of EHV-1, is suppressed at elevated temperatures. Notably, we show that single nucleotide polymorphism (SNPs) in ORF30, which encodes the viral DNA polymerase UL30, and which have been implicated in EHM, are linked to the ability of EHV-1 to replicate at elevated temperatures. These findings suggest that replication at febrile temperature is a viral property relevant to EHV-1 pathogenesis and EHM risk.

    2026Microbiology spectrum(2026)
    引用
    AI阅读
    加入学术空间
    4Plasma and Urinary Concentrations of Synephrine in Horses Following Controlled Oral Administration.
    Y Minamijima, T Miida, M Mori, D Arima, H Ito, M Araki, Y Ishikawa, T Kuroda, G N Leung, K Kinoshita, M Yamada

    Synephrine is a sympathomimetic alkaloid of regulatory interest in both horse racing and equestrian sports, where feed‑related exposure may lead to its detection in equine blood and urine. This study characterized plasma and urinary concentrations of synephrine in horses following controlled oral administration. Six Thoroughbred horses received single oral doses of 100 mg or 800 mg synephrine, and blood and urine samples were collected sequentially. Each sample was analyzed both before and after β‑glucuronidase hydrolysis, demonstrating that synephrine was present predominantly as conjugated metabolites in both plasma and urine, and that hydrolysis substantially increased measurable concentrations. Non‑compartmental analysis was used to determine selected pharmacokinetic parameters, including half‑life, Cmax, Tmax, and AUC. These pharmacokinetic results indicated that synephrine was rapidly absorbed, with dose‑related increases in both systemic and urinary exposure. The findings provide initial quantitative information on circulating and urinary synephrine following defined oral exposure in horses. The concentration ranges and detection patterns described here may assist in interpreting field detections and support future studies aimed at understanding exposure arising from feed‑borne sources.

    2026Journal of equine veterinary science(2026)
    引用
    AI阅读
    加入学术空间
    5Serological Surveillance of Equine Herpesvirus Types 1 and 4 in Mongolia
    Dulam Purevtseren,Odonchimeg Myagmarsuren,Otgonsuren Davaajav, Batsuren Nanzaddorj, Davaanyam Nyamtseren, Ochirvaani Bumantsetseg,Enkhmandakh Yondonjamts,Enkhbaatar Batmagnai,Battsetseg Badgar,Badgar Battsetseg,Punsantsogvoo Myagmarsuren,Erdenechimeg Dashzevge

    Introduction Equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4) are major viral pathogens of horses causing respiratory disease, abortion and neurological disorders, leading to significant economic losses worldwide. In Mongolia, horses are raised under nomadic and extensive grazing systems, which may facilitate disease transmission. Nationwide data are scarce on the prevalence of infection with these viruses, and to generate these data for a broad expanse of Mongolia, surveillance was carried out. Material and Methods Large-scale serological testing was conducted using peptide-based ELISAs. A total of 1,222 serum samples were collected from horses across 12 provinces of Mongolia. Results Antibodies against EHV-1 were detected in 6.7% of samples, antibodies against EHV-4 in 20.7%, and antibodies against both in 2.8%. Overall, 301 horses (24.6%) were positive for at least one virus. The seroprevalence of EHV-4 was significantly higher than that of EHV-1 (P-value < 0.0001). Conclusion These findings provide baseline epidemiological data for Mongolia and support the development of risk-based surveillance and control strategies to reduce the impact of equine herpesvirus infections.

    2026Journal of Veterinary Research(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 234 篇论文

    合作机构(90)

    北海道大学合作论文 12
    东京大学合作论文 9
    东京农业科技大学合作论文 9
    岐阜大学合作论文 7
    Laboratory of Racing Chemistry合作论文 7
    Japan Racing Association合作论文 7
    Hidaka Hospital合作论文 7
    奥尻大学农兽医学部合作论文 7
    肯塔基大学合作论文 5
    加利福尼亚大学戴维斯分校合作论文 5

    机构统计